Hybrid machine learning model predicts CKD progression in Stage 3 adults using longitudinal data
Study tests machine learning model to predict kidney disease progression
An observational cohort study of CKD Stage 3 adults used NHANES data to test a hybrid machine learning framework (XLA) for predicting progre…
Tracking health changes over time helps predict worsening kidney disease better than a single medical test, according to new analysis.
Lixisenatide shows no effect on arterial stiffness in type 2 diabetes with chronic kidney disease
Study finds diabetes drug lixisenatide did not improve artery stiffness in kidney disease patients
A single-center, proof-of-concept randomized controlled trial in 90 people with type 2 diabetes and chronic kidney disease found that 24 wee…
A diabetes drug did not soften arteries in people with kidney disease, showing no improvement in a key heart risk factor after 24 weeks of t…
Serial serum creatinine monitoring may detect early GFR decline above 60 mL/min before CKD stage 3
Could tracking your own creatinine history spot kidney trouble earlier?
A descriptive article presents a method using serial serum creatinine referenced to an individual's historical maximum to monitor GFR above …
Tracking your own creatinine levels over time may spot early kidney trouble before standard tests catch it, offering a practical way to moni…
Shift work associated with 43% higher odds of chronic kidney disease in meta-analysis
Shift work linked to higher odds of chronic kidney disease in adults
A systematic review and meta-analysis of 12 observational studies in adults found shift workers had 43% higher odds of chronic kidney diseas…
Adults who work night or rotating shifts have about 43% higher odds of developing chronic kidney disease compared to those working regular d…
Genetic testing identified positive findings in 24% of CKD patients and changed management in most cases
Genetic testing found helpful for diagnosis and management in some chronic kidney disease patients.
A single-arm, prospective multicenter study of 1388 CKD patients found that 385-gene panel testing yielded positive genetic findings in 24% …
Genetic testing helped doctors diagnose and manage chronic kidney disease for 86% of patients with positive results and 42% with negative re…
Meta-analysis finds 2% mean prevalence of class 1 revascularization indications in prekidney transplant CAD screening
Pre-kidney transplant heart screening rarely finds severe blockages needing immediate surgery
A meta-analysis of 44 prekidney transplant screening studies found a mean 2% prevalence of American Heart Association class 1 indications fo…
Most people screened before kidney transplants do not have severe heart blockages requiring immediate surgery, according to a review of 44 s…
Omega-3 fatty acids may reduce CRP in haemodialysis patients, but evidence is limited
Omega-3 supplements may reduce inflammation in kidney dialysis patients
A meta-analysis of 678 haemodialysis patients found omega-3 supplementation reduced C-reactive protein more than comparators in specific sub…
Omega-3 supplements linked to lower inflammation markers in kidney dialysis patients, especially at daily doses under 2000 mg and in natural…
High albumin-corrected anion gap linked to increased MACE risk in CKD patients after PCI
Study links higher blood gap measure to more heart problems in kidney disease patients
A retrospective cohort study of 973 chronic kidney disease patients undergoing percutaneous coronary intervention found that a high albumin-…
Higher levels of a specific blood marker found in kidney disease patients are linked to more heart attacks, strokes, and heart-related death…
TRACK trial to assess low-dose rivaroxaban for MACE in advanced CKD/dialysis patients
Can a low-dose blood thinner protect people with advanced kidney disease from heart attacks and strokes?
The TRACK trial is a global, quadruple-blind, placebo-controlled phase 3 study evaluating low-dose rivaroxaban (2.5 mg) for reducing major a…
A new global study tested whether a low-dose blood thinner safely protects people with advanced kidney disease from heart attacks and stroke…